NARI - Inari Medical Inc Stock Price, Fair Value and News

$79.97

Market Closed

NARI Stock Valuation Analysis

Valuation

Max Portfolio %

NARI Price Action

NARI RSI Chart

NARI Stock Valuation Analysis

Valuation

Max Portfolio %

NARI Valuation

NARI Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

NARI Fundamentals

NARI Revenue

NARI Earnings

NARI Profitability

NARI Investor Care

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	520.7M	547.5M	574.5M	0
2023	412.9M	439.1M	469.3M	493.6M
2022	306.3M	335.6M	358.9M	383.5M
2021	170.1M	208.2M	242.4M	277.0M
2020	71.1M	86.5M	110.9M	139.7M
2019	0	21.6M	36.4M	51.1M
2018	0	0	0	6.8M

Get all data in R, Python etc through our Historical Stock Data APIs

About Inari Medical Inc

Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy systems for the specific disease states in the United States. The company provides ClotTriever, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

CEO	Mr. Andrew J. Hykes
WEBSITE	inarimedical.com
SECTOR	Healthcare
INDUSTRY	Medical Devices
EMPLOYEES	1100